Abstract

ROLE OF ACT 12 AND ACT 13, A PHYTOCONSTITUENTS COMPLEX AS A POTENTIAL THERAPY FOR MANAGEMENT OF COVID 19: A COMPREHENSIVE CASE STUDY REPORT

Dr. Shridhar Pandya*, Ghanshyam Goti and Dr. K. M. Gajera

Abstract

In lack of definite treatment for COVID-19 and prophylaxis regarding COVID-19 is deficient drugs discovered from Nutraceutical and phytoconstituents can reveal some promise for the development of interventions against COVID-19 infection. The purpose of the study is to present the clinical finding and outcomes of around 100 subjects of mild to moderate Covid 19 disease, who have been administered with ACT12 and ACT 13 together with standard of care to explore the potential of the intervention. Considering evidences from past research on ACT 12 and 13 together with the clinical observations of 100 subjects it can be concluded that ACT 12 and 13 could be a frontline option for early recovery, improving symptomatology and overall prognosis in patients with mild to moderate Covid 19. Surely the phytoconstituents based composition of ACT 12 and 13 holds promise to patients and healthcare stakeholders as safe and efficacious intervention in Covid 19 as therapeutic and prophylaxis as well.

Keywords: COVID-19, SARS-Cov-2, Nutraceutical, Phytoconstituents.